由买买提看人间百态

topics

全部话题 - 话题: arqule
(共0页)
m****g
发帖数: 530
1
WOBURN, Mass.--(BUSINESS WIRE)--Mar 31, 2010 - ArQule, Inc. (Nasdaq: ARQL)
today announced that
ARQ 197, when used in combination with erlotinib, demonstrated a 66%
improvement in median
Progression-Free Survival (PFS) in patients with advanced, refractory non-
small cell lung cancer (NSCLC). In
the intent to treat (ITT) population (n = 167), median PFS was 16.1 weeks in
the ARQ 197 plus erlotinib
arm, compared with 9.7 weeks in the erlotinib plus placebo arm.
The difference in PFS between the t
y***n
发帖数: 4103
2
这两天升的很厉害啊,这个公司的股票大家怎么看?
w****r
发帖数: 245
3
大侠,分类都分好了,求神签
# Basic Materials, Agricultural Chemicals
AGU Agrium Inc.
AVD American Vanguard Corp.
CAGC China Agritech Inc.
CF CF Industries Holdings, Inc.
CGA China Green Agriculture, Inc.
CMP Compass Minerals International
COIN Converted Organics Inc.
IPI Intrepid Potash, Inc.
MON Monsanto Co.
MOS Mosaic Co.
NOEC New Oriental Energy & Chemical
POT Potas... 阅读全帖
p***o
发帖数: 714
4
来自主题: _pennystock版 - Re: ZT: EXEL
【 以下文字转载自 Stockcafeteria 俱乐部 】
发信人: jhsph07 (银杏), 信区: Stockcafeteria
标 题: Re: ZT: EXEL
发信站: BBS 未名空间站 (Mon Jul 6 11:51:53 2009, 美东)
基本的意思是说, EXEL是做KI的, KI的成功率大概是40%左右, EXEL的pipeline
上面大概有11个KI, 如果按统计规律, 应该有5个最后会被FDA
批准。
等果实最终成熟大概还需要两年的时间。
Exelixis proves skeptics wrong
Dec 19, 2008
Another company that gives its shareholders reasons to smile is Exelixis, following the mammoth deal with BMS. Exelixis licensed its most advanced compound, XL184, and its early stage RAF inhibitor, XL281 in a de... 阅读全帖
g******0
发帖数: 1165
5
来自主题: _pennystock版 - 【药股】ASCO 2010
Mark T. writes, "Thank you for all your wonderful insight into Cell
Therapeutics(CTIC). I was able to make some money on this stock because of
your input. On another note, I am invested now in Celldex Therapeutics(CLDX)
. Have you ever written about them? Can you provide us with some of your
insight here? Is it the next Dendreon(DNDN)?"
Celldex's lead drug, CDX-110, is a cancer immunotherapy (so, a cancer "
vaccine" cousin to Dendreon's Provenge) targeting glioblastoma multiforme (
GBM) aka brai... 阅读全帖
y*****l
发帖数: 5997
6
来自主题: _pennystock版 - CLDX.6月7号那个大瀑布是怎么回事?
那天很多数据结果好的公司都瀑布了,除了sell on news,还有担心公司被低价收购。
ASCO会议的黑色星期一:ARIA,ARRY,CLDX,OXGN,PCYC...
Celldex also reported data on its metastatic melanoma treatment and a
bladder cancer treatment at the ASCO meeting. Still, shares plunged 19.7% to
$5.27. Celldex declined to comment about the share movement.
Roth analyst, Joseph Pantginis, said it was likely investors were selling on
the news as shares had been up 40% year-to-date before Monday's fall, last
month hitting as high as $9.49. But Pantginis said the... 阅读全帖
w***y
发帖数: 2537
7
来自主题: _pennystock版 - Events and ER for week August 2-6 (转载)
【 以下文字转载自 Stock 讨论区 】
发信人: ll111 (Stealth), 信区: Stock
标 题: Events and ER for week August 2-6
发信站: BBS 未名空间站 (Sun Aug 1 22:47:17 2010, 美东)
Monday, Aug. 2
10 a.m.: ISM Manufacturing index on business activity in July, released by
the Institute for Supply Management.
10:15 a.m. Federal Reserve Chairman Ben Bernanke speaking on "challenges for
the economy and state governments."
4 p.m. Treasury Secretary Timothy Geithner speaking on the next steps for
financial reform.
Tuesday, Aug. 3
8:30 a.m.: P... 阅读全帖
y*****l
发帖数: 5997
(共0页)